Beryl Drugs Limited (BERLDRG.BO)

INR 39.0

(-0.41%)

Annual Income Statements

(In INR)
Breakdown 2024 2023 2022 2021 2020 2019
Revenue 271.24 Million 267.05 Million 144.54 Million 138.43 Million 125.67 Million 126.39 Million
Cost of Revenue 162.74 Million 185.8 Million 104.36 Million 94.58 Million 86.13 Million 88.19 Million
Gross Profit 108.5 Million 81.25 Million 40.18 Million 43.85 Million 39.54 Million 38.19 Million
Operating Expenses 93.77 Million 69.34 Million 46.73 Million 41.92 Million 37.08 Million 31.05 Million
Selling, General and Administrative Expenses - 44.14 Million 21.29 Million 18.88 Million 22.15 Million 20.26 Million
Research and Development Expenses - - - - - -
Other Expenses 93.77 Million 2.57 Million 1.51 Million 1.69 Million 2.14 Million 1.81 Million
Cost and Expenses 256.51 Million 255.14 Million 151.09 Million 136.5 Million 123.21 Million 119.25 Million
Operating Income 14.73 Million 11.92 Million -6.54 Million 1.98 Million 2.71 Million 7.25 Million
Interest Expense 4.63 Million 4.17 Million 4.2 Million 4.27 Million 2.96 Million 1.34 Million
Income Tax Expense 2.41 Million 2.17 Million -2.91 Million 1.08 Million 1.09 Million 2.05 Million
Earnings before Tax 10.09 Million 9.83 Million -9.5 Million 3.48 Million 1.57 Million 7.96 Million
Net Income 7.68 Million 7.66 Million -6.59 Million 2.39 Million 479.41 Thousand 5.9 Million
Earnings Per Share Basic 1.52 1.51 -1.30 0.47 0.09 1.16
Earnings Per Share Diluted 1.52 1.51 -1.30 0.47 0.09 1.16
Weighted Average Shares Outstanding 5.05 Million 5.07 Million 5.07 Million 5.07 Million 5.07 Million 5.07 Million
Weighted Average Shares Outstanding (Diluted) 5.05 Million 5.07 Million 5.07 Million 5.07 Million 5.07 Million 5.07 Million
Gross Margin 0.40 0.30 0.28 0.32 0.31 0.30
EBIT Margin 0.10 0.08 0.04 0.12 0.09 0.10
Profit Margin 0.03 0.03 -0.05 0.02 0.00 0.05
EBITDA 26.63 Million 22.34 Million 5.57 Million 20.67 Million 11.12 Million 12.39 Million
Earnings Before Tax Margin 0.05 0.04 -0.05 0.01 0.02 0.06

Income Statement Charts